News Medical1d
Scientists uncover cerebrospinal fluid markers for Alzheimer's detection and treatment
Researchers map the unique genetic regulation of proteins in human cerebrospinal fluid, identifying potential targets for ...
Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal 3Q 2024 Results
Advancing investigation of [212Pb]VMT01 as a monotherapy and in combination with the anti-PD-1 antibody, nivolumab, in patients with previously ...
labiotech1d
Sleep apnea: biotechs snore points in the therapeutic space
While these are effective techniques, therapeutic strides are proving to help address different stages of the disease. Sleep ...
Intercept Receives Complete Response Letter from FDA Addressing OCALIVA supplemental New Drug Application (sNDA)
The FDA informed Intercept that it is unable to approve the sNDA in its current form, consistent with the outcome of the Gastrointestinal Drugs Advisory Committee (GIDAC) meeting in September 2024. In ...
total-croatia-news4d
Here’s What Will Function Despite Croatian Health Care Strike
The Croatian health care strike is set for Monday. Despite this, emergency and urgent medical situations will still be dealt ...
TMCnet6d
Rapport Therapeutics Reports Third Quarter Financials and Provides Business Update
Research and development expense was $15.5 million for the third quarter of 2024, as compared to $7.6 million for the prior year period. The increase in research and development expense was primarily ...